It makes me sad when I read of other patients relapsing
after battling so hard, but I know that is an aspect of the multiple myeloma
world that we all face. Right now, I am
in remission but I know that sometime in the future I, too, will relapse. It is
comforting to know that there are many new drugs in the pipeline for multiple
myeloma and that two new drugs are on schedule to be approved in 2012 in the
United States.
When I was undergoing my stem cell transplant, one of my
physician’s assistants told my husband and me to remember that all the longevity
estimates for MM patients are based on history and to keep in mind that with the
advances being made, treatments are becoming more effective in dealing with the
disease. Those were reassuring words
and I have thought about them many times.
In an earlier post, I mentioned a seminar I had
the good fortune to attend in Seattle at Fred Hutchinson Cancer Research Center moderated
by Andrew Schorr of Patient Power. This seminar featured William
Bensinger, MD, Director, Autologous Marrow Transplants at Seattle Cancer Care Alliance
and Noopur Raje, MD, Director, Center for Multiple Myeloma at Massachusetts
General Hospital. Here is a link to a video of the seminar:
I am including it again because I think it is important and
may provide encouragement to my fellow multiple myeloma patients and readers. My
husband, daughter and I came away from this seminar feeling heartened and
we were filled with hope for the future.
No comments:
Post a Comment